Ruben Colman, MD, PhD, Director of Intestinal Ultrasound at Stanford Medicine Prioritizing personalized care for children and adolescents with inflammatory bowel diseases (IBD) is critical to achieve early disease control and alleviate the long-term risks of IBD. A promising tool, a point-of-care intestinal ultrasound (IUS), offers a transformative approach that allows real-time, non-invasive images of … Read more
The number of Hongkongers suffering from incurable chronic gut conditions could surge by 150 per cent over a 20-year period due to unhealthy diets, high in sugar and fat, according to a global study. Scientists from the study that was co-led by researchers from Hong Kong and Canada raised the alarm after a projection model … Read more
Share on PinterestDifferent types of dairy products may have divergent effects on the gut, a new study suggests. Design by MNT; Photography by Grace Cary/Getty Images & Westend61/Getty Images. A healthy gut microbiome is essential for an overall healthy digestive system. Different foods impact the gut microbiome in different ways. A new study has found … Read more
Archyde IBD Patients: Navigating Barriers to Care and Medication Access Table of Contents 1. IBD Patients: Navigating Barriers to Care and Medication Access 2. The scope of the Access Problem 3. Insurance-Related Challenges 4. Comparing Cardiovascular Risks of IBD Therapies 5. Ustekinumab vs. Vedolizumab: A Closer Look 6. Implications for Clinicians and Patients 7. Key … Read more
Barriers to timely access to care and possible cardiovascular (CV) complications associated with therapies used to treat inflammatory bowel disease (IBD), were identified by researchers and shared at the Crohn’s & Colitis Congress, the annual meeting of the Crohn’s & Colitis Foundation. Inflammatory bowel disease is an umbrella term for Crohn disease and ulcerative colitis. … Read more
A real world study in an adolescent and young adult inflammatory bowel disease (IBD) population found no significant differences in key laboratory markers or disease activity in patients who remained on the originator (Remicade) compared with those who switched to the biosimilar CT-P13 (Inflectra; infliximab-dyyb). Dosing regimens and the development of antidrug antibodies were also … Read more
Early onset inflammatory bowel disease (IBD) activity post-diagnosis is associated with a higher incidence of psychiatric diagnoses and psychotropic medication usage, according to a study published in Crohn’s & Colitis 360.1 Patients with IBD exhibit a higher prevalence of comorbid conditions, with concurrent psychiatric disease diagnoses contributing to a substantial part of their disability, particularly … Read more